 |
|
Long Term Therapeutic Plan for Patients with Non-Small Cell Lung Cancer Harboring
Seung Hun Jang
Tuberc Respir Dis. 2014;76(1):8-14. Published online 2014 Jan 29 DOI: https://doi.org/10.4046/trd.2014.76.1.8
|
|
Citations to this article as recorded by
 High-Throughput Prediction of the Impact of Genetic Variability on Drug Sensitivity and Resistance Patterns for Clinically Relevant Epidermal Growth Factor Receptor Mutations from Atomistic Simulations
Aristarc Suriñach, Adam Hospital, Yvonne Westermaier, Luis Jordà, Sergi Orozco-Ruiz, Daniel Beltrán, Francesco Colizzi, Pau Andrio, Robert Soliva, Martí Municoy, Josep Lluís Gelpí, Modesto Orozco
Journal of Chemical Information and Modeling.2023; 63(1): 321. CrossRef Integration of traditional Chinese medicine and Western medicine in the era of precision medicine
Wen-jian Wang, Teng Zhang
Journal of Integrative Medicine.2017; 15(1): 1. CrossRef Mutations in tyrosine kinase and tyrosine phosphatase and their relevance to the target therapy in hematologic malignancies
Ni Zhu, Haowen Xiao, Li-Mengmeng Wang, Shan Fu, Chan Zhao, He Huang
Future Oncology.2015; 11(4): 659. CrossRef Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure
Kyoung Min Cho, Bhumsuk Keam, Tae Min Kim, Se-Hoon Lee, Dong-Wan Kim, Dae Seog Heo
The Korean Journal of Internal Medicine.2015; 30(6): 891. CrossRef
|